RDSN.F Stock Overview

Develops, markets, and sells monitoring systems for medical treatments primarily in Europe and the United States. More details

RDSN.F fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	3/6
Dividends	0/6

Risk Analysis

Has less than 1 year of cash runway

Earnings have declined by 1.2% per year over past 5 years

Shares are highly illiquid

Does not have a meaningful market cap ($115M)

+ 2 more risks

My Notes

Capture your thoughts, links and company narrative

Redsense Medical AB (publ) Competitors

Ekso Bionics Holdings

NasdaqCM:EKSO

US$16.1m

Aspira Women's Health

NasdaqCM:AWH

US$12.0m

STRATA Skin Sciences

NasdaqCM:SSKN

US$12.8m

Scientific Industries

OTCPK:SCND

US$10.9m

Price History & Performance

Summary of share price highs, lows and changes for Redsense Medical
Historical stock prices
Current Share Price	SEK 0.51
52 Week High	SEK 1.05
52 Week Low	SEK 0.51
Beta	0.49
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-49.00%

Recent updates

Shareholder Returns

	RDSN.F	US Medical Equipment	US Market
7D	0%	1.6%	1.3%
1Y	n/a	9.5%	24.4%

Return vs Industry: Insufficient data to determine how RDSN.F performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how RDSN.F performed against the US Market.

Price Volatility

Is RDSN.F's price volatile compared to industry and market?
RDSN.F volatility
RDSN.F Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	8.6%
Market Average Movement	6.4%
10% most volatile stocks in US Market	18.6%
10% least volatile stocks in US Market	3.2%

Stable Share Price: RDSN.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine RDSN.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2000	5	Sebastien Bollue	redsensemedical.com

Redsense Medical AB (publ) develops, markets, and sells monitoring systems for medical treatments primarily in Europe and the United States. The company offers Redsense System, a medical technology product that is used for monitoring and alarming in the event of blood leakage in connection with a hemodialysis treatment. It also provides Redsense Clamp, which clamps the bloodline to stop blood flow when the alarm unit detects a blood leakage.

Redsense Medical AB (publ) Fundamentals Summary

How do Redsense Medical's earnings and revenue compare to its market cap?
RDSN.F fundamental statistics
Market cap	US$10.78m
Earnings (TTM)	-US$373.36k
Revenue (TTM)	US$2.30m

4.7x

P/S Ratio

-28.9x

P/E Ratio

Is RDSN.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RDSN.F income statement (TTM)
Revenue	SEK 24.49m
Cost of Revenue	SEK 10.13m
Gross Profit	SEK 14.36m
Other Expenses	SEK 18.33m
Earnings	-SEK 3.98m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Nov 26, 2024

Earnings per share (EPS)	-0.24
Gross Margin	58.63%
Net Profit Margin	-16.24%
Debt/Equity Ratio	0%

How did RDSN.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/10/30 04:29
End of Day Share Price	2024/08/02 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Redsense Medical AB (publ) is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Maria Karlsson Osipova	Penser Access